Pivotal Scientific Limited supported Atlas Antibodies in their decision making on … Read more
Pivotal Scientific advises Antibody BCN on its sale to CliniSciences
CliniSciences adds to its portfolio of companies
Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology company AbBcn S.L. (AntibodyBCN) to the French distribution company CliniSciences. The acquisition will broaden CliniSciences product portfolio for customised production of antibodies and distribution.
AbBcn S.L. approached PSL for assistance in finding potential buyers. PSL used its extensive database and expert knowledge of the global biotech landscape, approached companies looking to buy and facilitated this introduction.
“Companies are reaching out to us regularly when looking to Merge, Acquire or wanting to investigate management buyouts. AbBcn S.L. reached out and we were able to find a suitable buyer very quickly for them. A great addition to CliniSciences portfolio”
Tim Bernard, CEO, Pivotal Scientific Limited
Sign up to our newsletter for the latest Industry insights and new technologies
Pivotal Scientific Limited (PSL) is pleased to announce … Read more
Pivotal Scientific are delighted to have advised the … Read more
Release Date: July 31st, 2019 Seattle, Washington State, … Read more
A successful transaction benefitting both parties. Pivotal Scientific … Read more
CliniSciences adds to its portfolio of companies Pivotal … Read more